Company Profile
Photocure provides the research, development, production, distribution, marketing, and sale of pharmaceutical products. Its business is organized into two segments, Commercial Franchise and Development Portfolio.
The company offers Hexvix/Cysview for the detection and management of bladder cancer. It is also developing Cevira, a photodynamic drug-device combination product candidate for the non-surgical treatment of high-grade cervical dysplasia.
The company has a license agreement with Asieris MediTech Co to develop and commercialize Cevira a strategic agreement with Richard Wolf GmbH to develop and commercialize a 4K LED high-definition reusable blue light cystoscope based on Richard Wolf's System blue technology.
Products are distributed to pharmaceutical wholesalers, pharmacies, and hospitals through license partners. The company operates in the Nordic countries, Germany, France, Austria, the United Kingdom, the Benelux, Italy, other European countries, Canada, and the United States. Founded in 1993, Photocure is headquartered in Oslo, Norway.